Related references
Note: Only part of the references are listed.Low Vitamin D among HIV-Infected Adults: Prevalence of and Risk Factors for Low Vitamin D Levels in a Cohort of HIV-Infected Adults and Comparison to Prevalence among Adults in the US General Population
Christine N. Dao et al.
CLINICAL INFECTIOUS DISEASES (2011)
Increased Rates of Bone Fracture among HIV-Infected Persons in the HIV Outpatient Study (HOPS) Compared with the US General Population, 2000-2006
Benjamin Young et al.
CLINICAL INFECTIOUS DISEASES (2011)
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
Grace A. McComsey et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans
Julie A. Womack et al.
PLOS ONE (2011)
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis
Mark J. Bolland et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase
Tanya Welz et al.
AIDS (2010)
Short Communication: Inadequate Vitamin D Exacerbates Parathyroid Hormone Elevations in Tenofovir Users
Kathryn E. Childs et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D
Todd T Brown et al.
ANTIVIRAL THERAPY (2010)
Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study
Hans-Juergen Stellbrink et al.
CLINICAL INFECTIOUS DISEASES (2010)
Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers
Grace A. McComsey et al.
CLINICAL INFECTIOUS DISEASES (2010)
Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women A Randomized Controlled Trial
Kerrie M. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients
Claudine Duvivier et al.
AIDS (2009)
Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
Todd T. Brown et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma
Matteo Landriscina et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large US healthcare system
Virginia A. Triant et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17
M. Hashizume et al.
RHEUMATOLOGY (2008)
HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development
Eoin J. Cotter et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV
Grace A. McComsey et al.
AIDS (2007)
RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men
Davide Gibellini et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years
Mark J. Bolland et al.
CLINICAL ENDOCRINOLOGY (2007)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Annual zoledronate increases bone density in highly active Antiretroviral therapy-treated human immunodeficiency virus-infected men: A randomized controlled trial
Mark J. Bolland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The incidence and natural history of osteonecrosis in HIV-Infected adults
Caryn G. Morse et al.
CLINICAL INFECTIOUS DISEASES (2007)
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review
Todd T. Brown et al.
AIDS (2006)
Longitudinal analysis of bone density in human immunodeficiency virus-infected women
Sara E. Dolan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
HIV-1 Vpr enhances production of receptor of activated NF-kappa B ligand (RANKL) via potentiation of glucocorticoid receptor activity
JM Fakruddin et al.
ARCHIVES OF VIROLOGY (2005)
Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
JE Gallant et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Weight loss: A determinant of hip bone loss in older men and women - The Rancho Bernardo Study
JD Knoke et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor κB ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-γ/RANKL cross-talk
JM Fakruddin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Fanconi syndrome and renal failure induced by tenofovir: A first case report
D Verhelst et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Changes in bone mineral density with age in men and women: A longitudinal study
L Warming et al.
OSTEOPOROSIS INTERNATIONAL (2002)
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
P Tebas et al.
AIDS (2000)
Share Paper
